Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65. https://doi.org/10.1038/nrneurol.2017.104.

Article  PubMed  Google Scholar 

Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369–79. https://doi.org/10.1159/000509802.

Article  PubMed  Google Scholar 

Thorell SE, Parry-Jones AR, Punter M, Hurford R, Thachil J. Cerebral venous thrombosis-a primer for the haematologist. Blood Rev. 2015;29(1):45–50. https://doi.org/10.1016/j.blre.2014.09.006.

Article  PubMed  Google Scholar 

de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30(3):484–8. https://doi.org/10.1161/01.str.30.3.484.

Article  PubMed  Google Scholar 

Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis [published correction appears in Lancet 1991 Oct 12;338(8772):958]. Lancet. 1991;338(8767):597–600. https://doi.org/10.1016/0140-6736(91)90607-q.

Article  PubMed  Google Scholar 

Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011;2011(8):CD002005. https://doi.org/10.1002/14651858.CD002005.pub2.

Article  PubMed  PubMed Central  Google Scholar 

Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–92. https://doi.org/10.1161/STR.0b013e31820a8364.

Article  PubMed  Google Scholar 

Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–13.

Article  PubMed  CAS  Google Scholar 

Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139(11):893–900. https://doi.org/10.7326/0003-4819-139-11-200312020-00007.

Article  PubMed  Google Scholar 

Lowenstern A, Al-Khatib SM, Sharan L, et al. Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2018;169(11):774–87. https://doi.org/10.7326/M18-1523.

Article  PubMed  PubMed Central  Google Scholar 

Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report [published correction appears in Chest. 2016 Oct;150(4):988. https://doi.org/10.1016/j.chest.2016.08.1442]. Chest. 2016;149(2):315–352. https://doi.org/10.1016/j.chest.2015.11.026

Shahid R, Zafar A, Nazish S, et al. An observational study comparing the safety and efficacy of conventional anticoagulation versus new oral anticoagulants in the management of cerebral venous sinus thrombosis. Prim Care Companion CNS Disord. 2021;23(6):21m02927. https://doi.org/10.4088/PCC.21m02927.

Article  PubMed  Google Scholar 

Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, et al. RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMANeurol. 2019;76:1457–65. https://doi.org/10.1001/jamaneurol.2019.2764.

Article  Google Scholar 

Field TS, Dizonno V, Almekhlafi MA, et al. Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis. Stroke. 2023;54(11):2724–36. https://doi.org/10.1161/STROKEAHA.123.044113.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nirhale S, Rohatgi S, Rao P, Naphade P, Hatekar KS. Study of use of dabigatran in cerebral venous sinus thrombosis. Cureus. 2024;16(7):e64744. https://doi.org/10.7759/cureus.64744.

Article  PubMed  PubMed Central  Google Scholar 

Liu K, Pei L, Gao Y, et al. Dehydration status predicts short-term and long-term outcomes in patients with cerebral venous thrombosis. Neurocrit Care. 2019;30(2):478–83. https://doi.org/10.1007/s12028-018-0628-3.

Article  PubMed  Google Scholar 

Liu K, Song B, Gao Y, et al. Long-term outcomes in patients with anemia and cerebral venous thrombosis. Neurocrit Care. 2018;29(3):463–8. https://doi.org/10.1007/s12028-018-0544-6.

Article  PubMed  Google Scholar 

Yaghi S, Shu L, Bakradze E, et al. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022;53(3):728–38. https://doi.org/10.1161/STROKEAHA.121.037541.

Article  PubMed  CAS  Google Scholar 

Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008;26(4):381–7. https://doi.org/10.1159/000151678.

Article  PubMed  Google Scholar 

Qureshi AI. A classification scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol. 2010;3(1):1–2.

PubMed  PubMed Central  Google Scholar 

Yaghi S, Saldanha IJ, Misquith C, et al. Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis. Stroke. 2022;53(10):3014–24. https://doi.org/10.1161/STROKEAHA.122.039579.

Article  PubMed  CAS  Google Scholar 

Wang Z, Dandu C, Guo Y, et al. A novel score to estimate thrombus burden and predict intracranial hypertension in cerebral venous sinus thrombosis. J Headache Pain. 2023;24(1):29. https://doi.org/10.1186/s10194-023-01562-9.

Article  PubMed  PubMed Central  Google Scholar 

Herweh C, Griebe M, Geisbüsch C, Szabo K, Neumaier-Probst E, Hennerici MG, Bendszus M, Ringleb PA, Nagel S. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur J Neurol. 2016;23:681–7. https://doi.org/10.1111/ene.12901.

Article  PubMed  CAS  Google Scholar 

Khorvash F, Farajpour-Khanaposhtani MJ, Hemasian H, Saadatnia SM. Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: a case-control blinded study. Curr J Neurol. 2021;20(3):125–30. https://doi.org/10.18502/cjn.v20i3.7687.

Article  PubMed  PubMed Central  Google Scholar 

Arauz A, Vargas-González JC, Arguelles-Morales N, et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J Neurol Neurosurg Psychiatry. 2016;87(3):247–51. https://doi.org/10.1136/jnnp-2014-310068.

Article  PubMed  Google Scholar 

Coutinho JM, Zuurbier SM, Bousser MG, et al. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966–73. https://doi.org/10.1001/jamaneurol.2020.1022.

Article  PubMed  PubMed Central  Google Scholar